These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 5125063)

  • 1. [Preliminary psychological findings during treatment of the parkinsonian syndrome with amantadine. Preliminary observations].
    Barbieri NF; Megna GF; Micalizzi V; Pigneri MT; Puca FM
    Minerva Med; 1971 Oct; 62(82):4000-3. PubMed ID: 5125063
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electrophysiological findings during treatment of the parkinsonian syndrome with amantadine].
    Di Perri R; Livrea P; Messina C; Puca FM; Tomasello F
    Minerva Med; 1971 Oct; 62(82):3997-9. PubMed ID: 4331007
    [No Abstract]   [Full Text] [Related]  

  • 3. [Psychological changes in parkinsonian patients during L-DOPA, amantidine, and L-DOPA + IDC treatment (author's transl)].
    Puca FM; Megna GF; Masi G; Specchio LM
    Riv Patol Nerv Ment; 1974 Oct; 95(5):676-84. PubMed ID: 4470268
    [No Abstract]   [Full Text] [Related]  

  • 4. [Psychologic evaluation of amantadine treatment of parkinsonism and comparative analysis of the effects with L-dopa].
    Puca FM; Micalizzi V; Megna GF; Barbieri NF; Pigneri MT
    Acta Neurol (Napoli); 1971; 26(6):707-30. PubMed ID: 4946491
    [No Abstract]   [Full Text] [Related]  

  • 5. [Amantadine and L-Dopa in the treatment of parkinsonian syndromes].
    Kluzer G; Lampo B
    Minerva Med; 1971 Oct; 62(82):4013-4. PubMed ID: 5125067
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preliminary results of the use of amantadine in parkinsonian syndromes].
    Montanari M; Monaco V; Robotti CA
    Minerva Med; 1971 Oct; 62(82):3955-7. PubMed ID: 5125050
    [No Abstract]   [Full Text] [Related]  

  • 7. [Amantadine and L-Dopa in the treatment of parkinsonian syndromes and their implications for rehabilitation].
    Raspa EG; Paciaroni E; Saccomanno G
    Minerva Med; 1971 Oct; 62(82):4031-5. PubMed ID: 5125073
    [No Abstract]   [Full Text] [Related]  

  • 8. [The therapeutic association of L-dopa and amantadine. Preliminary results in a group of patients with Parkinson's disease].
    Gomirato G; Perfetti C
    Riv Neurobiol; 1970; 16(3):247-54. PubMed ID: 5518838
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa].
    Ambrosetto C; Martinelli P
    Minerva Med; 1971 Oct; 62(82):4017-9. PubMed ID: 5125069
    [No Abstract]   [Full Text] [Related]  

  • 10. [Psychological status of patients with Parkinsonism during treatment with amantadine hydrochloride and L-Dopa].
    Ferraris M
    Minerva Med; 1971 Oct; 62(82):3971-3. PubMed ID: 5125056
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes].
    Ciuca I; Bulandra R; Serbanesco A; Ninosu N
    Rev Neurol (Paris); 1972 Aug; 127(2):305-8. PubMed ID: 4672049
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary observations on the use of intravenous amantadine and of the association of oral amantadine with anticholinergic drugs and with levo-dopa in the treatment of Parkinson's disease].
    Fasano VA; Urciuoli R; Broggi G
    Minerva Med; 1970 Jul; 61(53):2895-903. PubMed ID: 5428170
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of parkinsonian states with L-dopa].
    Boudin G; Guillard A; Pépin B
    Bull Acad Natl Med; 1971 Nov; 155(28):707-12. PubMed ID: 4948142
    [No Abstract]   [Full Text] [Related]  

  • 14. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
    Reveno WS; Bauer RB; Rosenbaum H
    Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prolonged treatment of Parkinson's disease with amantadine and L-Dopa].
    Fieschi C; Casacchia M; Nardini M; Reitano N
    Minerva Med; 1971 Oct; 62(82):4040-2. PubMed ID: 5125075
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects induced by the treatment with amantadine on habituation of trigemino-facial reflexes in Parkinsonian patients].
    Messina C; Tomasello F
    Riv Neurol; 1972; 42(2):202-8. PubMed ID: 4341955
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of parkinsonism with L-Dopa and amantadine.
    Green J
    J Fla Med Assoc; 1970 Jun; 57(6):28-33. PubMed ID: 5445813
    [No Abstract]   [Full Text] [Related]  

  • 18. [Amantadine in the treatment of transitory hypokinesia in patients with parkinsonism during therapy with L-Dopa].
    De Divitiis E; D'Andrea F; Signorelli CD; Cerillo A
    Minerva Med; 1971 Oct; 62(82):4007-8. PubMed ID: 5125065
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of 1-adamantil-amine chlorhydrate on parkinsonian asynkinesia].
    Megna G
    Acta Neurol (Napoli); 1971; 26(6):701-6. PubMed ID: 4946490
    [No Abstract]   [Full Text] [Related]  

  • 20. [Amantadine hydrochloride in the treatment of Parkinson's syndrome].
    De la Herrán J; Figuerido JA
    Rev Esp Otoneurooftalmol Neurocir; 1971; 29(167):45-9. PubMed ID: 5091472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.